TGF‐β1 serum concentration as a complementary diagnostic biomarker of lung cancer: establishment of a cut‐point value
Authors:
- Ana E. González‐SantiagoAGAna E. González‐Santiago
- Luz A. Mendoza‐TopeteLMLuz A. Mendoza‐Topete
- Francisco Sánchez‐LlamasFSFrancisco Sánchez‐Llamas
- Rogelio Troyo‐SanrománRTRogelio Troyo‐Sanromán
- Carmen M. Gurrola‐DíazCGCarmen M. Gurrola‐Díaz
- 1 January 2011
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 25 (4) , 238-243
Abstract
Lung cancer is a malignant disease with increasing mortality rates. Cytokines play a role in normal cell growth regulation and differentiation and are also implicated in malignant disease. Among these cytokines, Transforming Growth Factor β type 1 (TGF‐β1) acts as a tumor promoter in malignant cells. Several clinical studies have found high levels of TGF‐β1 in various cancer types. The aim of this study was to establish a TGF‐β1 cut‐off point as a complementary diagnostic tool in lung cancer detection. Therefore, 72 clinically well‐characterized individuals were studied, 41 lung cancer patients and 31 healthy subjects. Serum TGF‐β1 concentration was measured by an enzyme‐linked immunosorbent assay (ELISA). We compared statistically the serum TGF‐β1 concentration between both groups with analysis of variance, linear regression and receiver operating curve analysis. We observed that lung cancer patients produced higher TGF‐β1 levels than healthy individuals (37,225±9,436 vs. 28,416±9,324 pg/ml, PConclusions: We found significantly higher TGF‐β1 levels in lung cancer patients than in healthy individuals. We propose the measurement of serum TGF‐β1 levels as a complementary diagnostic test in lung cancer detection. J. Clin. Lab. Anal. 25:238–243, 2011.Keywords
This publication has 36 references indexed in Scilit:
- Circulating transforming growth factor-β1 levels and the risk for kidney disease in African AmericansKidney International, 2009
- Elevated plasma TGF-β1 levels in patients with chronic obstructive pulmonary diseaseRespiratory Medicine, 2009
- Increased Transforming Growth Factor-beta1 in Alcohol DependenceJournal of Korean Medical Science, 2009
- Elevated serum level and gene polymorphisms of TGF‐β1 in gastric cancerJournal of Clinical Laboratory Analysis, 2008
- Usefulness of contrast-enhanced magnetic resonance imaging for evaluating solitary pulmonary nodulesCancer Imaging, 2008
- Population screening for lung cancer using computed tomography, is there evidence of clinical effectiveness? A systematic review of the literatureThorax, 2007
- Opposite effect of corticosteroids and long‐acting β2‐agonists on serum‐ and TGF‐β1‐induced extracellular matrix deposition by primary human lung fibroblastsJournal of Cellular Physiology, 2006
- Cigarette Smoke Causes Small Airway Remodeling by Direct Growth Factor Induction and ReleaseProceedings of the American Thoracic Society, 2006
- Tobacco Smoking and Lung Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiological Evidence Among the Japanese PopulationJapanese Journal of Clinical Oncology, 2006
- Plasma transforming growth factor-?1 level before radiotherapy correlates with long term outcome of patients with lung carcinomaCancer, 1999